COTE D'IVOIRESIERRA LEONECAPACITY BUILDINGSTRENGTHENING SYSTEMS AND HEALTH SERVICESFighting HIV / AIDSInfectious and emerging diseases
Context :
Despite significant progress in access to ART (Antiretroviral Therapy), the number of deaths related to HIV/AIDS remains well above the set targets. Advanced HIV disease (AHD) (WHO stage 3 or 4 or
CD4<200 cells/mm3), associated with a high number of opportunistic infections, is one of the main causes of these deaths. AHD therefore represents a major challenge in the global fight against HIV, particularly in
sub-Saharan Africa, where the coverage of recommended interventions is suboptimal due to multifactorial barriers and gaps along the care cascade.
Key information :
| Project Duration | : 3.5 years (01/2024 – 06/2027) |
| Partners |
|
| Beneficiaries | Some 15 health establishments in Cote d’Ivoire (cohort of around 5,500 PLHIV monitored) and 11 health establishments in Sierra Leone (cohort of around 12,000 PLHIV monitored). |
| Source of funding | UNITAID |
| Country of intervention |
Sierra Leone and Cote d’Ivoire |
General objective :
Prevent deaths in adults and children by simplifying the advanced management of HIVrelated illnesses.
Expected results :
- R1: Provide evidence-based data by implementing a decentralized model, rigorous monitoring, and scientific projects.
- R2: Improve the availability of products for AHD, particularly CD4 tests (Managed by MAA).
- R3: Prepare countries and support their transitions.
- R4: Promote community advocacy and demand generation with a human-centered approach (Managed by MAA).
- R5: Encourage global advocacy and partner coordination to expand advanced HIV care, combining communication, collaboration, and engagement (Led by Aurum)
